References
- Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature461(7267), 1071–1078 (2009).
- Espinosa E, Zamora P, Feliu J, González Barón M. Classification of anticancer drugs – a new system based on therapeutic targets. Cancer Treat. Rev.29(6), 515–523 (2003).
- Weinberg RA. The Biology of Cancer. Garland Science, NY, USA, (2007).
- Fong PC, Boss DS, Yap TA et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med.361(2), 123–134 (2009).
- Patel DJ, Phan AT, Kuryavyi V. Human telomere, oncogenic promoter and 5´-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res.35(22), 7429–7455 (2007).
- Eddy J, Maizels N. Gene function correlates with potential for G4 DNA formation in the human genome. Nucleic Acids Res.34(14), 3887–3896 (2006).
- Eddy J, Maizels N. Conserved elements with potential to form polymorphic G-quadruplex structures in the first intron of human genes. Nucleic Acids Res.36(4), 1321–1333 (2008).
- Huppert JL, Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res.33(9), 2908–2916 (2005).
- Huppert JL, Balasubramanian S. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res.35(2), 406–413 (2007).
- De Cian A, Cristofari G, Reichenbach P et al. Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc. Natl Acad. Sci. USA104(44), 17347–17352 (2007).
- Paeschke K, Simonsson T, Postberg J, Rhodes D, Lipps HJ. Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo. Nat. Struct. Mol. Biol.12(10), 847–854 (2005).
- Cahoon LA, Seifert HS. An alternative DNA structure is necessary for pilin antigenic variation in Neisseria gonorrhoeae. Science325(5941), 764–767 (2009).
- Sarkies P, Reams C, Simpson LJ, Sale JE. Epigenetic instability due to defective replication of structured DNA. Mol. Cell40(5), 703–713 (2010).
- Law MJ, Lower KM, Voon HP et al. ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell143(3), 367–378 (2010).
- Gomez D, Wenner T, Brassart B et al. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J. Biol. Chem.281(50), 38721–38729 (2006).
- Rizzo A, Salvati E, Porru M et al. Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway. Nucleic Acids Res.37(16), 5353–5364 (2009).
- Salvati E, Scarsella M, Porru M et al. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. Oncogene29(47), 6280–6293 (2010).
- Drygin D, Siddiqui-Jain A, O’Brien S et al. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res.69(19), 7653–7661 (2009).
- Brooks TA, Hurley LH. Targeting MYC expression through G-quadruplexes. Genes Cancer1(6), 641–649 (2010).
- Müller S, Kumari S, Rodriguez R, Balasubramanian S. Small-molecule-mediated G-quadruplex isolation from human cells. Nat. Chem.2(12), 1095–1098 (2010).
- Rodriguez R, Müller S, Yeoman JA, Trentesaux C, Riou JF, Balasubramanian S. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J. Am. Chem. Soc.130(47), 15758–15759 (2008).
- Camphausen K, Tofilon PJ. Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J. Clin. Oncol.25(26), 4051–4056 (2007).
- Miller KM, Tjeertes JV, Coates J et al. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat. Struct. Mol. Biol.17(9), 1144–1151 (2010).
Website
- Quadparser: a program for finding putative quadruplexes in DNA sequences. www.quadruplex.org/?view=quadparser